home > drugs a-z list > rhophylac (immune globulin intravenous (human) solution) drug center > rhophylac (immune globulin intravenous (human) solution) drug - overdosage and contraindications

There are no reports of known overdoses in patients being treated for suppression of Rh isoimmunization or ITP. Patients with incompatible transfusion or ITP who receive an overdose of Rh₀(D) immune globulin should be monitored because of the risk of hemolysis.

Individuals known to have had an anaphylactic or severe systemic reaction to the administration of human immune globulin products should not receive Rh₀(D) immune globulin.

Last reviewed on RxList: 5/18/2007
This monograph has been modified to include the generic and brand name in many instances.